Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here. Galena Biopharma, Inc. (Nasdaq: GALE) announced it intends to offer shares of its common stock and warrants to purchase its …
Billionaire hedge fund managers such as Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down high-potential small-cap stocks and pouring cash into these …
Galena Biopharma, Inc’s GALE shares plunged 82.8% after the company announced that it has discontinued the phase III PRESENT study on its lead candidate, NeuVax (nelipepimut-S). The decision followed the …
Galena
Feb. 08, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing ... Each unit consists of one full share of its common stock and a warrant to purchase one share of …
Galena Biopharma
(Original Source) Shares of Galena Biopharma closed yesterday at 1.96, down $0.02 or -1.01%. GALE has a 1 …
NASDAQ
Galena Biopharma looks like it's going to have an incredible day in the market today. While the trading session hasn't opened quite yet, the stock is already seeing massive pre-market gains. Below, we'll talk about what …
Galena Biopharma
Galena Biopharma, Inc. (GALE) saw a big move last session, as the company’s shares fell by 6% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. …
Galena Biopharma Inc (NASDAQ:GALE) shares are down big today after the company announced plans for a secondary stock offering. With Raymond James & Associates hired as the sole book-running manager for the …
ir.net416y